15.03.2012 • NewsHovioneGuy VillaxGuy Villax Hovione

Colin Minchom Appointed VP Particle Design BU at Hovione

Hovione said it has appointed Dr. Colin Minchom as vice president of its Particle Design business unit. Dr. Minchom was most recently with Patheon where he held the position of vice president, Pharmaceutical Development Services for North America. Based in East Windsor, NJ, Dr. Minchom will report to Hovione CEO Guy Villax.

Dr. Minchom's 29-year career includes extensive experience in the process, science and global regulation of drug development with emphasis on dosage forms and drug delivery. Prior to this role at Patheon, Dr. Minchom was head of Pharmaceutical Sciences at Cerebrus, a UK privately held pharmaceutical company and has also held positions of increasing scientific and management responsibility at Eli Lilly and E.R. Squibb in formulation and product development, project management and product management.

 

 

Company

Hovione

Sete Casas
2674-506 Loures
Portugal

Company contact







Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.